Artisan Partners
BCRX icon

Artisan Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Artisan Partners’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,837,924
Closed -$23.7M – 308
2023
Q1 		$23.7M Sell
2,837,924
-40,503
-1% -$390K 0.04% 250
2022
Q4 		$33M Buy
2,878,427
+228,811
+9% +$2.85M 0.06% 236
2022
Q3 		$33.4M Sell
2,649,616
-267,593
-9% -$3.44M 0.06% 234
2022
Q2 		$30.9M Buy
2,917,209
+75,804
+3% +$782K 0.05% 237
2022
Q1 		$46.2M Buy
2,841,405
+175
+0% +$2.81K 0.06% 238
2021
Q4 		$39.4M Sell
2,841,230
-10,154
-0.4% -$134K 0.05% 268
2021
Q3 		$41M Sell
2,851,384
-292,101
-9% -$4.61M 0.05% 256
2021
Q2 		$49.7M Buy
3,143,485
+117,879
+4% +$1.6M 0.06% 240
2021
Q1 		$30.8M Buy
+3,025,606
New +$31.2M 0.04% 292

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return